Caffo O, Amichetti M, Tomio L, Galligioni E
Department of Medical Oncology, St. Chiara Hospital, 38100, Trento, Italy.
Radiother Oncol. 2001 Apr;59(1):13-20. doi: 10.1016/s0167-8140(00)00264-4.
Standard therapy in early-stage testicular seminoma (TS) includes inguinal orchiectomy followed by irradiation (XRT) of the pelvic and para-aortic nodes. Since this treatment is highly effective in controlling the disease and leads to many long survivors, the quality of life (QL) may be impaired by treatment-induced side-effects. The aim of this study was to provide a QL evaluation of patients treated with XRT after orchiectomy for TS.
We used a validated self-completed questionnaire based on a series of 44 items covering all QL fields. The items were grouped into six subscales with standardized scores. The questionnaire was mailed to a consecutive series of 143 patients treated between 1961 and 1995 for TS with no evidence of disease after primary treatment.
Ninety-eight questionnaires (68.5%) were returned and are assessable. The median age of the patients was 48 years (range, 26-85 years) at the time of completing the questionnaire, with a median follow-up after completion of treatment of 123 months (range, 15-432 months). The physical and autonomy subscale standardized scores were > or =1 in 83 and 95% of the cases, respectively. Psychological problems were reported by a small percentage of patients, ranging from 13, who reported a depressive condition, to 16%, who declared feeling tense. Of the patients, 86 and 89% have regularly met relatives and friends. The urinary score was above the central point in 99% of the patients. Only 6% of the patients perceived their body image as worsened by treatment. The patients who were more informed about the disease and therapy had a better physical and psychological adjustment.
The QL in our patients resulted as satisfactory, with a maintained body image and few side-effects. The information given to the patients about their disease and its treatment influenced the post-treatment QL adjustment.
早期睾丸精原细胞瘤(TS)的标准治疗包括腹股沟睾丸切除术,随后对盆腔和腹主动脉旁淋巴结进行放疗(XRT)。由于这种治疗在控制疾病方面非常有效,并能使许多患者长期存活,治疗引起的副作用可能会损害生活质量(QL)。本研究的目的是对睾丸精原细胞瘤患者睾丸切除术后接受XRT治疗的生活质量进行评估。
我们使用了一份经过验证的自我填写问卷,该问卷基于一系列涵盖所有生活质量领域的44个项目。这些项目被分为六个子量表,并给出标准化分数。问卷被邮寄给1961年至1995年间连续治疗的143例TS患者,这些患者在初次治疗后无疾病证据。
98份问卷(68.5%)被退回并可进行评估。患者填写问卷时的中位年龄为48岁(范围26 - 85岁),治疗完成后的中位随访时间为123个月(范围15 - 432个月)。身体和自主子量表的标准化分数分别在83%和95%的病例中≥1。一小部分患者报告有心理问题,报告抑郁状态的患者占13%,称感到紧张的患者占16%。86%和89%的患者定期与亲戚和朋友见面。99%的患者尿液评分高于中心点。只有6%的患者认为治疗使他们的身体形象变差。对疾病和治疗了解更多的患者在身体和心理方面的调整更好。
我们患者的生活质量令人满意,身体形象得以维持,副作用较少。向患者提供的关于其疾病及其治疗的信息影响了治疗后的生活质量调整。